Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6302951 | 0.92 | CNR2 (0.47) | CNR2CYP2C19ALDH1A1CYP2C9CNR1 | |
| SCHEMBL13086171 | 0.89 | LMNA (0.43) | CNR2ALDH1A1RAB9AKEAP1NFE2L2 | |
| SCHEMBL17491037 | 0.89 | CNR2 (0.41) | CNR2CYP2C19ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL13086504 | 0.85 | SMN1; SMN2 (0.43) | CNR2CYP2C19ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL12298626 | 0.84 | RAB9A (0.42) | CNR2CYP2C19ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL4443205 | 0.82 | CYP2D6 (0.44) | CNR2CYP2C19ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL8606105 | 0.82 | APP (0.33) | — | |
| SCHEMBL9347243 | 0.81 | LTA4H (0.38) | CNR2CYP2C19ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL244232 | 0.81 | CNR2 (0.35) | CNR2CYP2C19ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL11145734 | 0.81 | APP (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2129788-B1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS LLC (US) | 2014-09-03 | — | — | EP | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | CNR2 2139/4885CYP2C19 3617/4885ALDH1A1 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.